Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.
about
Transitional Cell Carcinoma of the Bladder Manifestating as Malignant Lymphoma with Generalized Lymphadenopathy.Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice: combination with phytochemical compositionRole of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder.Involvement of Seladin-1 in goniothalamin-induced apoptosis in urinary bladder cancer cells.Treatment of muscle-invasive bladder cancer: progress and new challenges.Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects.In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancerRandomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder.
P2860
Q34059556-19B54BBD-3252-4521-ACA3-9E2FE50EAFC5Q34360256-60E0230B-ED14-4F36-B5A6-2F736D90DC47Q35125750-82475720-BB76-4352-A5B1-AAFAD2165DBAQ35222174-7B957044-B9C7-4157-A131-5A930CFF59C7Q35987756-24F9F29B-BD74-4CA7-854C-88065FD1828EQ36334885-D1183A51-2A1A-449F-AA9A-7018B1BE527AQ36612195-B7F3FB98-C0B3-4F7B-B0F1-C322AF7AE644Q37085946-C44AEC68-2E67-40B7-9DCD-FF15D134C94CQ37474079-2245239F-5AFD-4E72-98F6-5B7F01F0546FQ37660290-EF8FEEED-A170-4271-8D5F-A9D3FC20159AQ46044443-8296F268-543D-4141-9E25-5F9C446E42CD
P2860
Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Systemic chemotherapy for pati ...... versies and future directions.
@ast
Systemic chemotherapy for pati ...... versies and future directions.
@en
type
label
Systemic chemotherapy for pati ...... versies and future directions.
@ast
Systemic chemotherapy for pati ...... versies and future directions.
@en
prefLabel
Systemic chemotherapy for pati ...... versies and future directions.
@ast
Systemic chemotherapy for pati ...... versies and future directions.
@en
P2093
P1476
Systemic chemotherapy for pati ...... versies and future directions.
@en
P2093
Andrew S Protheroe
Geoffrey D Hall
John D Chester
Martin Forster
P304
P356
10.1016/J.CTRV.2003.12.005
P577
2004-06-01T00:00:00Z